DocDollars

Pacira Therapeutics, Inc.

MA · United States · Reporting entity ID 100000291812

Total reported 2019–2025
$12.6M
#430 of 2,960 reporting companies — 0% of all reported industry payments
$3.78M in general payments across 39,860 records, plus $8.83M in research funding across 160 records.

How it breaks down

General payments $3,779,769
Research funding $8,834,558

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Pacira Therapeutics, Inc. reported $12.6M to US doctors and teaching hospitals from 2019 to 2025, ranking #430 of 2,960 reporting companies. 70% of that was research funding and 30% general payments such as consulting, speaking, food and travel. 39,860 general payment records and 160 research records were filed.

Common questions about Pacira Therapeutics, Inc.

How much has Pacira Therapeutics, Inc. paid US doctors?

Pacira Therapeutics, Inc. reported $12,614,327 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $3,779,769 in general payments, $8,834,558 in research funding.

How does Pacira Therapeutics, Inc. rank among drug and device companies?

It ranks #430 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Pacira Therapeutics, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.